SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
oseltamivir
Journals
5
1
Indian journal of pediatrics
2
Vaccine
3
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
4
dermatologic therapy
5
nuklearmedizin nuclear medicine
Research Groups
0
No Research Group Connected
Bibliographies
27
1
Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
2
Influenza.
3
Pharmacists' impact on older adults' access to vaccines in the United States.
4
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?
5
Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.
6
clinical evaluation of selected pharmacological treatments used for coronavirus (covid-19) pandemic
7
intravenous anti-influenza drug oseltamivir will not induce torsade de pointes: evidences from proarrhythmia model and action-potential assay
8
viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza a(h7n9) virus in zhejiang, china, 2013
9
Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
10
Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
11
Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity
12
Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial
13
Effects of Oseltamivir Treatment on Duration of Clinical Illness and Viral Shedding and Household Transmission of Influenza Virus
14
treatment of immunocompromised, critically ill patients with influenza a h1n1 infection with a combination of oseltamivir, amantadine, and zanamivir
15
strategies for the use of oseltamivir and zanamivir during pandemic outbreaks
16
a new ion selective electrode method for determination of oseltamivir phosphate (tamiflu) and its pharmaceutical applications
17
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
18
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
19
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study
20
Resistant influenza A viruses in children treated with oseltamivir: descriptive study
21
Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China
22
Oral oseltamivir treatment of influenza in children
23
Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza
24
Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome
25
Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002—2003 Influenza Season
26
A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons
27
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice